FDA Inspection 1248477 — Anesta LLC

Anesta LLC — FEI 1000149927

The FDA completed an inspection of Anesta LLC on August 30, 2024 in Salt Lake City, UT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 30, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Salt Lake City, UT (United States)